Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 11/11/2024Dizal Submits NDA to FDA for Sunvozertinib in EGFR Exon20ins NSCLC Tre...
  • 11/11/2024China Approves Second KRAS-G12C Inhibitor, Garsorasib, Co-developed by...
  • 11/11/2024Precision Bio's CD19-Targeted CAR-T Therapy, pCAR-19B, Selected for Or...
  • 11/11/2024Alphamab Reports Results of FIH Clinical Study of Anti-HER2 ADC and PD...
  • 11/8/2024Recent Executive Moves
  • 11/8/2024Bayer China Launches OPERA 2.0 Healthcare Platform
  • 11/8/2024AstraZeneca Clarifies: Investigation into China Exec Unrelated to Ongo...
  • 11/8/2024Ping An Health and Medtronic Form Strategic Partnership at the CIIE
  • 11/8/2024Pfizer Ignite Partners with Beijing Mabworks to Develop Novel MM Thera...
  • 11/8/2024Nuwacell Secures CNY 150M in First Close of Series B Financing to Acce...
  • 11/8/2024Junshi Reports on Phase II Trial of Toripalimab in Combo with Gemcitab...
  • 11/8/2024Cathay Innovation Partners with Sanofi to Establish a New Fund For In...
  • 11/8/2024Takeda Initiates Phase 3 Trials in China for Sleep Disorder Drug TAK-8...
  • 11/8/2024Henlius, XtalPi Sign Deals to Expand Abroad as Chinese Drug Companies ...
  • 11/8/2024Santen, Arctic Vision Sign Deal for ARVN001 to Treat UME
  • 11/7/2024Pfizer Unveils $1B 'China 2030 Strategy' at CIIE to Advance Innovation...
  • 11/7/2024Aditum Bio and Leads Biolabs Forms JV Oblenio Bio to Develop a Tri-Spe...
  • 11/7/2024Minghui Pharma Announces Promising Initial Results from Phase I Trial ...
  • 11/7/2024AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designation...
  • 11/7/2024CStone Announces Patent Publication for First-in-Class ADC CS5006
  • 11/7/2024CDE Issues the Notice on the Technical Requirements for Pilot Registra...
  • 11/7/2024A Share-Listed Pharma Companies Report Solid Performance in Q3/2024
  • 11/6/2024MNCs and Chinese Partners Join Forces to Build an Innovative Healthcar...
  • 11/6/2024Innovent Cancels 20% Stake Sale Amid Investor Concerns
  • 11/6/2024Novartis Highlights Commitment to China's Market at CIIE
  • 11/6/2024Pharma Firms Present Innovative Treatments for Major Diseases at CIIE
  • 11/6/2024BioCity Presents Late-Breaking Phase 2 Results for IgA Nephropathy Tre...
  • 11/6/2024Novo Nordisk Reports Strong Growth in China for 3Qs of 2024, Driven by...
  • 11/6/2024Shenyang Biotech Secures Pre-A Series Funding to Advance Peptide Vacci...
  • 11/6/2024NMPA Accepts AbbVie's BLA for Epcoritamab (Epkinly) for Lymphomas
  • Page:11/42 Total number of articles:1234: [First][<<] [9] [10] [11] [12] [13] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group